Bone marrow stromal function from patients after bone marrow transplantation

Area of Science:

• Hematology
• Stem Cell Biology
• Immunology

Background:

• Allogeneic bone marrow transplantation (BMT) is a critical therapy for hematologic malignancies.
• Assessing the hematopoietic supporting capacity of bone marrow stroma post-BMT is crucial for understanding long-term recovery.
• Long-term bone marrow culture (LTBMC) models are utilized to evaluate stromal cell function.

Purpose of the Study:

• To evaluate the hematopoietic supporting ability of bone marrow stromal cells in patients following BMT.
• To assess the functional capacity of bone marrow stroma to support primitive hematopoietic stem cells (CD34+/CD38-) post-transplant.

Main Methods:

• A two-stage long-term bone marrow culture (LTBMC) system was employed.
• Irradiated bone marrow stromal cells from BMT recipients were co-cultured with CD34+/CD38- cells from normal donors.
• Granulocyte/macrophage colony-forming cell (GM-CFC) output was monitored weekly to assess hematopoietic support.

Main Results:

• Neutrophil recovery was rapid post-BMT, but granulocyte/macrophage colony-forming cell (GM-CFC) recovery was significantly reduced in most patients up to 5 years.
• 58% of patients exhibited compromised bone marrow stroma, with deficits in supporting primitive hematopoietic cells (CD34+/CD38-).
• These deficits in hematopoietic support persisted for several years in some BMT recipients.

Conclusions:

• Bone marrow stroma in BMT recipients demonstrates compromised hematopoietic supporting ability, particularly for primitive stem cells.
• The functional deficits in bone marrow stroma can persist for years, impacting long-term hematopoietic recovery.
• LTBMC is a valuable tool for assessing stromal cell function and identifying long-term complications after BMT.